# Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

> **NCT03806478** · PHASE2 · UNKNOWN · sponsor: **Aphios** · enrollment: 60 (estimated)

## Conditions studied

- Dementia
- Alzheimer Disease 1
- Alzheimer Disease 2
- Alzheimer Disease 3

## Interventions

- **DRUG:** APH-1105
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03806478
- **Lead sponsor:** Aphios
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03806478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03806478, "Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03806478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*